We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+0.42%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.12B
AUM Growth
+$762M
Cap. Flow
+$908M
Cap. Flow %
14.82%
Top 10 Hldgs %
15.76%
Holding
794
New
208
Increased
110
Reduced
107
Closed
121

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$85M
2
ABT icon
Abbott
ABT
+$72M
3
NVDA icon
NVIDIA
NVDA
+$60.9M
4
TER icon
Teradyne
TER
+$52.2M
5
LEGN icon
Legend Biotech
LEGN
+$50.2M

Top Sells

Rank Stock Value
1
APH icon
Amphenol
APH
+$98.7M
2
TXN icon
Texas Instruments
TXN
+$95.4M
3
GPN icon
Global Payments
GPN
+$54.3M
4
JNJ icon
Johnson & Johnson
JNJ
+$49.4M
5
KLAC icon
KLA
KLAC
+$49M

Sector Composition

Rank Sector Weight
1 Healthcare 46.26%
2 Technology 25.67%
3 Communication Services 8.98%
4 Financials 5.47%
5 Consumer Staples 3.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PASG icon
326
Passage Bio
PASG
$14.8M
$3.21M 0.05%
+16,090
New +$3.84M
NTNX icon
327
Nutanix
NTNX
$16.6B
$3.2M 0.05%
+84,765
New +$3.2M
GDRX icon
328
GoodRx Holdings
GDRX
$1.11B
$3.18M 0.05%
77,446
+44,939
+138% +$1.63M
FSNB
329
DELISTED
Fusion Acquisition Corp. II
FSNB
$3.16M 0.05%
324,992
– –
RNAM
330
DELISTED
Avidity Biosciences
RNAM
$3.15M 0.05%
128,000
– –
HNST icon
331
The Honest Company
HNST
$429M
$3.14M 0.05%
302,617
-3,884
-1% -$47.4K
LABP
332
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$3.11M 0.05%
21,280
-54
-0.3% -$7.01K
TNYA icon
333
Tenaya Therapeutics
TNYA
$172M
$3.1M 0.05%
+150,080
New +$3.22M
XENE icon
334
Xenon Pharmaceuticals
XENE
$6.19B
$3.06M 0.05%
+199,984
New +$3.48M
LYEL icon
335
Lyell Immunopharma
LYEL
$329M
$3.05M 0.05%
10,294
-14,684
-59% -$4.4M
PLRX icon
336
Pliant Therapeutics
PLRX
$65.6M
$3.04M 0.05%
179,993
+108,330
+151% +$2.3M
DHBC
337
DELISTED
DHB Capital Corp. Class A common stock
DHBC
$3.01M 0.05%
309,939
– –
CNDA.U
338
DELISTED
Concord Acquisition Corp II Units, each consisting of one share of Class A Common Stock and one-third of one Warrant
CNDA.U
$2.99M 0.05%
+300,000
New +$2.97M
BOWX
339
DELISTED
BowX Acquisition Corp. Class A Common Stock
BOWX
$2.99M 0.05%
+299,141
New +$3.07M
GLUE icon
340
Monte Rosa Therapeutics
GLUE
$1.31B
$2.99M 0.05%
134,033
-74,035
-36% -$2.12M
HWELU
341
DELISTED
Healthwell Acquisition Corp. I Unit
HWELU
$2.98M 0.05%
+300,000
New +$2.97M
RVACU
342
DELISTED
Riverview Acquisition Corp. Unit
RVACU
$2.98M 0.05%
+300,000
New +$2.97M
MSPR
343
DELISTED
MSP Recovery Inc
MSPR
$2.97M 0.05%
+69
New +$2.99M
IPAXU
344
DELISTED
Inflection Point Acquisition Corp. Units
IPAXU
$2.96M 0.05%
+300,000
New +$2.96M
SOND
345
DELISTED
Sonder
SOND
$2.96M 0.05%
14,996
– –
DOLE icon
346
Dole
DOLE
$1.32B
$2.96M 0.05%
+174,653
New +$2.69M
CCAIU
347
DELISTED
Cascadia Acquisition Corp. Unit
CCAIU
$2.95M 0.05%
+300,000
New +$2.96M
TBCP
348
DELISTED
Thunder Bridge Capital Partners III Inc. Class A Common Stock
TBCP
$2.93M 0.05%
300,000
– –
FRXB
349
DELISTED
Forest Road Acquisition Corp. II
FRXB
$2.92M 0.05%
300,000
– –
VLAT
350
DELISTED
Valor Latitude Acquisition Corp. Class A Ordinary Shares
VLAT
$2.92M 0.05%
+300,000
New +$2.9M
12 13
14
15 16

Similar funds

PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
VAI
Vanguard Advisers Inc Malvern, Pennsylvania $25.5B AUM

Woodline Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Woodline Partners held 794 positions worth $6.12B, up 14% from $5.36B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Woodline Partners deployed $908M of net new capital in Q3 2021, opening 208 new positions and adding to 110 existing holdings. Its largest new stake was Qualcomm: 599,018 shares worth $77.3M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, down from 47% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Amphenol, an estimated $98.7M trimmed.

  • Woodline Partners's largest Q3 2021 buy was Qualcomm: 599,018 shares worth $77.3M.
  • Woodline Partners added most to Teradyne in Q3 2021, an estimated $52.2M increase.
  • Woodline Partners's biggest Q3 2021 reduction was Amphenol, cutting an estimated $98.7M.
  • Woodline Partners fully exited Boston Scientific in Q3 2021, selling an estimated $44.9M.
  • Woodline Partners's ten largest holdings make up 16% of its $6.12B portfolio in Q3 2021.
  • Woodline Partners opened 208 new positions and closed 121 in Q3 2021.
  • Woodline Partners's portfolio value rose 14% quarter-over-quarter to $6.12B.

Based on Woodline Partners's 13F filing for Q3 2021, filed 15 Nov 2021.